Skip to main content

Peer Review reports

From: Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes

Original Submission
19 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
12 Aug 2022 Reviewed Reviewer Report
20 Aug 2022 Reviewed Reviewer Report
6 Sep 2022 Author responded Author comments - Jia Liu
Resubmission - Version 4
6 Sep 2022 Submitted Manuscript version 4
19 Sep 2022 Author responded Author comments - Jia Liu
Resubmission - Version 5
19 Sep 2022 Submitted Manuscript version 5
9 Oct 2022 Author responded Author comments - Jia Liu
Resubmission - Version 6
9 Oct 2022 Submitted Manuscript version 6
Publishing
17 Oct 2022 Editorially accepted
7 Dec 2022 Article published 10.1186/s12902-022-01233-x

You can find further information about peer review here.

Back to article page